Winslow Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-22
Closed -$3K 102
2018
Q4
$3K Sell
22
-3
-12% -$492 ﹤0.01% 87
2018
Q3
$5K Hold
25
﹤0.01% 82
2018
Q2
$4K Hold
25
﹤0.01% 78
2018
Q1
$4K Hold
25
﹤0.01% 77
2017
Q4
$4K Hold
25
﹤0.01% 85
2017
Q3
$5K Hold
25
﹤0.01% 76
2017
Q2
$6K Hold
25
﹤0.01% 77
2017
Q1
$6K Sell
25
-23
-48% -$5.36K ﹤0.01% 78
2016
Q4
$10K Sell
48
-1,246,968
-100% -$258M ﹤0.01% 73
2016
Q3
$287M Sell
1,247,016
-191,819
-13% -$46.9M 1.19% 34
2016
Q2
$333M Sell
1,438,835
-569,110
-28% -$131M 1.36% 30
2016
Q1
$538M Buy
2,007,945
+683,688
+52% +$196M 2.11% 13
2015
Q4
$414M Sell
1,324,257
-133,550
-9% -$39.8M 1.48% 26
2015
Q3
$396M Buy
+1,457,807
New +$448M 1.44% 27

Other funds holding AGN

Winslow Capital Management's AGN Position: Q1 2019 in Review

Winslow Capital Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 22 shares — an estimated $3K sold.

Winslow Capital Management first reported a position in AGN in Q3 2015 and held it in 14 quarters. The position peaked at $538M in Q1 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Winslow Capital Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Winslow Capital Management sold 22 Allergan plc shares in Q1 2019, an estimated $3K.
  • Winslow Capital Management first reported a position in Allergan plc in Q3 2015 and held it in 14 quarters.
  • Winslow Capital Management's Allergan plc position peaked at $538M in Q1 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Winslow Capital Management's 13F filing for Q1 2019, filed 14 May 2019.